HC Wainwright Analysts Give Check Cap (CHEK) a $14.00 Price Target

Share on StockTwits

HC Wainwright set a $14.00 target price on Check Cap (NASDAQ:CHEK) in a research note issued to investors on Tuesday morning. The brokerage currently has a buy rating on the medical research company’s stock.

Separately, Zacks Investment Research cut Check Cap from a buy rating to a hold rating in a research report on Tuesday, July 24th.

Check Cap stock traded down $0.15 during trading hours on Tuesday, reaching $3.74. 27,718 shares of the company were exchanged. Check Cap has a 12 month low of $3.08 and a 12 month high of $19.78.

Check Cap (NASDAQ:CHEK) last announced its earnings results on Monday, November 5th. The medical research company reported ($0.50) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.53) by $0.03. As a group, equities analysts predict that Check Cap will post -2.57 EPS for the current fiscal year.

A hedge fund recently bought a new stake in Check Cap stock. Fosun International Ltd acquired a new stake in Check Cap Ltd (NASDAQ:CHEK) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 127,558 shares of the medical research company’s stock, valued at approximately $517,000. Fosun International Ltd owned 7.97% of Check Cap at the end of the most recent quarter. 17.41% of the stock is currently owned by institutional investors.

About Check Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit worn on the patient's back for capsule control, tracking, and data recording; and C-Scan View, a personal computer-based software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface.

Featured Story: Google Finance Portfolio

Receive News & Ratings for Check Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply